Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 26, 2019
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
Giancarlo Comi, Raed Alroughani, Aaron L Boster, et al.
Journal of Neurology
|
May 31, 2018
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study
Ian Marshall, Michael J Thrippleton, Mark E Bastin, et al.
JAMA
|
January 16, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Richard K Burt, Roumen Balabanov, Joachim Burman, et al.
Bone Marrow Transplantation
|
September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
Raffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
November 22, 2025
Digital assessment of real-world walking in people with impaired mobility: How many hours and days are needed?
Joren Buekers, Julia Chernova, Sarah Koch, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
The Lancet. Neurology
|
January 26, 2020
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Jeremy Chataway, Floriana De Angelis, Peter Connick, et al.
BMJ Open
|
September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
Peter Connick, Floriana De Angelis, Richard A Parker, et al.
Trials
|
January 17, 2026
Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics
Gavin Brittain, Ellen Buckley, Vita Lanfranchi, et al.
Brain : a Journal of Neurology
|
October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progression
Jeff Rodgers, Tim Friede, Frederick W Vonberg, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 26, 2019
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
Giancarlo Comi, Raed Alroughani, Aaron L Boster, et al.
Journal of Neurology
|
May 31, 2018
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study
Ian Marshall, Michael J Thrippleton, Mark E Bastin, et al.
JAMA
|
January 16, 2019
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Richard K Burt, Roumen Balabanov, Joachim Burman, et al.
Bone Marrow Transplantation
|
September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party
Raffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
November 22, 2025
Digital assessment of real-world walking in people with impaired mobility: How many hours and days are needed?
Joren Buekers, Julia Chernova, Sarah Koch, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
The Lancet. Neurology
|
January 26, 2020
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Jeremy Chataway, Floriana De Angelis, Peter Connick, et al.
BMJ Open
|
September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
Peter Connick, Floriana De Angelis, Richard A Parker, et al.
Trials
|
January 17, 2026
Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics
Gavin Brittain, Ellen Buckley, Vita Lanfranchi, et al.
Brain : a Journal of Neurology
|
October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progression
Jeff Rodgers, Tim Friede, Frederick W Vonberg, et al.
Page
of 16